RWE

Views & Analysis
Demonstrating-the-value-of-RWE

Demonstrating the value of RWE

A new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional trials.

Views & Analysis
Harnessing RWE in rare diseases

Harnessing RWE in rare diseases

Ahead of eyeforpharma Philadelphia 2019, Sonal Bhatia, Pfizer’s vice president, North America medical lead, rare disease talked to us about the importance of collaboration and RWE to he